Preparation and in vitro properties of oridonin-loaded polylactic-acid nanoparticles

Chinese Pharmaceutical Journal

Volumn 42, Issue 13, 2007, Pages 1006-1010

  Xing, Jie ^a,b   Zhang, Dian Rui ^a   Zhang, Xue Shun ^c   Gao, Lei ^a  

^a SHANDONG UNIVERSITY   (China)

^b Zhongshan People's Hospital   (China)

^c Traditional Chinese Medicine Hospital of Shandong Province   (China)

Author keywords

In vitro release; Nanoparticles; Oridonin; Polylactic acid; Uniformity design

Indexed keywords

NANOPARTICLE; ORIDONIN; POLYLACTIC ACID;

ARTICLE; DIFFERENTIAL SCANNING CALORIMETRY; DIFFUSION; DRUG DELIVERY SYSTEM; DRUG RELEASE; EMULSION; PH MEASUREMENT; TRANSMISSION ELECTRON MICROSCOPY; ULTRACENTRIFUGATION; VISCOMETER; X RAY DIFFRACTION;

EID: 34547229708     PISSN: 10012494     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (23)

1. YANG Y W, XU X L, WANG D H, et al. Studies of molecular configuration of oridonin by 2D-NMR [J]. Acta Chem Sin, 1992,50:498-503.
2. CHEN S, GAO J, HALICKA H D, et al. The cytostatic and cytotoxic effects of oridonin (Rubescenin), a diterpenoid from Rabdosia rubescens,on tumor cells of different lineage [J]. Int J Onc, 2005,26:579-588.
3. ZHANG J F. CHEN G H, LU M Q, et al. Antiproliferation effects of oridonin on hepatocellular carcinoma BEL-7402 cells and its mechanism [J]. Chin Tradit Pat Med, 2006,28(9):1325-1329.
4. LIU J J, WU X Y, LU H L, et al. Anti-proliferation effect of oridonin on HL-60 cells and its mechanism [J]. Chin Med Sci J, 2004,19(2):134-137.
5. LIU M Y, FAN K S, FAN QX, et al. A study on apoptosis of human HCT8 cell induced by oridonin [J]. Henan J Oncol, 2004,3(17):167-168.
6. LI X T, LIN C, LI P Y. Comparison of in vitro assays for the cytotoxic effect of anticancer drugs [J]. Chin J Oncol, 1986,8(3):184-186.
7. ZHANG Y B, KOU X, LU J S, et al. Study on the inclusion of oridonin-β-cyclodextrin [J]. J Chin Med Mater, 1999,22(4):204-205.
8. ZHANG D R, REN T C. LOU HX, et al. Studies on preparation and property of oridonin solid lipid nanoparticels [J] . Chin Pharm J, 2004,39(2):123-126.
9. ZHANG D R, REN T C, LOU H X, et al. The tissue distribution in mice and pharmacokinetics in rabbits of oridonin solid lipid nanoparticles [J]. Acta Pharm Sin, 2005,40(6): 573-576.
10. SHI S P, YU J ,FENG N P, et al. Preparation and characterization of oridonin-loaded poly (caprolactone)-poly (ethylene oxide )-poly (caprolactone) copolymer nanoparticles [J]. Chin J Nat Med, 2005,3(5):291-293.
11. ZHANG S, TAN Z Y, CHEN J M. Polylactic acid polymer as the carrier of the delayed and controlled released injections [J]. Chin Pharm J, 2002,37(11):810-812.
12. MURAKAMI H, KOBAYASHI M, TAKEUCHI H, et al. Preparation of poly (D,L-lactide-co-glycolide) nanoparticles by modified spontaneous emulsification solvent diffusion method [J]. Int J Pharm ,1999,187:143-152.
13. HANCOCK B C, CARLSON G T, LADIPO D D, et al. Comparison of the mechanical properties of the crystalline and amorphous forms of a drug substance [J]. Int J Pharm, 2002,241(1):73-85.
14. CORRIGAN D O, HEALY A M, CORRIGAN O I. The effect of spray drying solutions of bendroflumethiazide/ polyethylene glycol on the physicochemical properties of the resultant materials [J]. Int J Pharm, 2003,262(1-2):125-137.
15. HYV NEN S, PELTONEN L, KARJALAINEN M, et al. Effect of nanoprecipitation on the physicochemical properies of low molecular weight poly(L-lactic acid) nanoparticles loaded with salbutamol sulphate and beclomethasone dipropionate [J]. Int J Pharm, 2005,295(1-2):269-281.
16. FONTANA G, PITARRESI G. TOMARCHIO V, et al. Preparation , characterization and in vitro antimicrobial activity of ampicillin-loaded polyethy Lcyanoacrylate nanoparticles [J]. Biomaterials, 19(1-2):1009-1017.
17. LIU M X, DONG J, YANG Y J, et al. Characterization and release of triptolide-loaded poly (D, L-lactic acid) nanoparticles [J]. Euro Pol J, 2005,41:375-382.
18. HUEPER W C. Carcinogenic studies on water-soluble and insoluble macromolecules [J]. Arch Pathol, 1959,67:589-617.
19. CARRIO A, SCHWACH G, COUDANE J, et al. Preparation and degradation of surfactant-free PLAGA microspheres [J]. J Controlled Release, 1991,37;113-121.
20. XU H B, YANG X L. Nano-Medicine [M]. Vol 1. Beijing: Tsinghua University Press, 2004:37-38.
21. HANCOCK B C, CARLSON G T, LADIPO D D, et al. Comparison of the mechanical properties of the crystalline and amorphous forms of a drug substance [J]. Int J Pharm, 2002,241(1):73-85.
22. CORRIGAN D O. HEALY A M, CORRIGAN O I. The effect of spray drying solutions of bendroflumethiazide/polyethylene glycol on the physicochemical properties of the resultant materials [J]. Int J Pharm, 2003,262(1-2):125-137.
23. ZAMBAUX M F, BONNEAUX F, GREF R, et al. Preparation and characterization of protein C-loaded PLA nanoparticles [J]. J Controlled Release, 1999,60(2-3):179-188.